IP Verse

Pharmaceutical Works Polpharma competitive analysis

Latest oppositions filed by Pharmaceutical Works Polpharma

Explore patent oppositions filed by Pharmaceutical Works Polpharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP1991267
Methods Of Treating Inflammatory And Autoimmune Diseases With NatalizumabBIOGEN IDEC MASep 20, 2018
EP2524060
Assay For Jc Virus AntibodiesBIOGEN IDEC MAAug 27, 2018
EP2645106
Methods And Products For Evaluating An Immune Response To A Therapeutic AgentBIOGEN IDEC MAMar 9, 2018
EP1925308
Low Hygroscopic Aripiprazole (Crystal G) Drug Substance And Processes For The Preparation ThereofOTSUKA PHARMACEUTICALApr 10, 2017
EP1734997
Steroid Sparing Agents And Methods Of Using SameBIOGEN IDEC MAJun 1, 2016
EP1944322
Treatment Of Tnf Alpha Related DisordersABBOTT BIOTECHNOLOGYDec 10, 2015
EP1872136
Methods And Products For Evaluating An Immune Response To A Therapeutic ProteinBIOGEN IDEC MANov 17, 2015
EP2350127
Isolation And Purification Of Antibodies Using Protein A Affinity ChromatographyABBOTT LABORATORIESOct 27, 2015
EP2203462
Nucleoside Phosphoramidate ProdrugsGILEAD PHARMASSETFeb 20, 2015

Latest PTAB cases involving Pharmaceutical Works Polpharma

Discover the latest PTAB cases involving Pharmaceutical Works Polpharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Pharmaceutical Works Polpharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
PHARMACEUTICAL WORKS POLPHARMA SA6 - - -
BIOGEN IDEC MA - 45 - 1
BIOGEN MA167 - 7
ELAN PHARMACEUTICALS - 9 - -